Washington: A new study has found that advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment.
Among the non-drinkers studied, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable serum at week 48; and 11 percent had a sustained virologic response. In contrast, the corresponding proportions for those who drank three or more cups of coffee per day were 73 percent, 52 percent, 49 percent and 26 percent, respectively. The study appeared in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. IANS